Skip to content
healthcare.dev
Get a free key

Naproxen Sodium Diphenhydramine Hydrochloride

NDC 21130-814, Naproxen Sodium Diphenhydramine Hydrochloride, tablet, from SAFEWAY.

Product NDC
21130-814
Status
Listed
Labeler
SAFEWAY
Dosage form
TABLET
Route
ORAL
Product type
HUMAN OTC DRUG
Marketing category
ANDA
Application
ANDA213663
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/21130-814 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • NAPROXEN SODIUM220 mg/1
  • DIPHENHYDRAMINE HYDROCHLORIDE25 mg/1

Pharmacologic classes

Anti-Inflammatory Agents, Non-Steroidal [CS]; Cyclooxygenase Inhibitors [MoA]; Histamine H1 Receptor Antagonists [MoA]; Histamine-1 Receptor Antagonist [EPC]; Nonsteroidal Anti-inflammatory Drug [EPC]

Package NDCNDC-11Package
21130-814-052113008140550 TABLET in 1 BOTTLE (21130-814-05)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 21130-814 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/21130-814 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 21130-814. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.